Jenkem Technology Co

Jenkem Technology Co Intangible Assets

The Intangible Assets of Jenkem Technology Co (688356.SS) as of Nov 5, 2026 is 40.00 M CNY. In the previous year, Intangible Assets was 20.00 M CNY — a change of 100.00% (higher).

Intangible Assets

40.00 MCNY

YoY

100.00%

Last updated:

Intangible Assets of Jenkem Technology Co is 2024 40.00 M CNY. Intangible Assets of Jenkem Technology Co was 2023 20.00 M CNY. It decreases by 100.00% higher compared to the previous year.

The Jenkem Technology Co Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
17.40 M CNY
Jan 1, 2018
16.90 M CNY
Jan 1, 2019
16.60 M CNY
Jan 1, 2020
17.00 M CNY
Jan 1, 2021
21.14 M CNY
Jan 1, 2022
20.64 M CNY
Jan 1, 2023
20.00 M CNY
Jan 1, 2024
40.00 M CNY
The Jenkem Technology Co Intangible Assets history
YEARIntangible AssetsYoY
40.00 MCNY+100.00%
20.00 MCNY-3.12%
20.64 MCNY-2.33%
21.14 MCNY+24.33%
17.00 MCNY+2.41%
16.60 MCNY-1.78%
16.90 MCNY-2.87%
17.40 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Jenkem Technology Co Stock analysis

What does Jenkem Technology Co do? Jenkem Technology Co., Ltd. generates revenue through the research, development, production, and sales of medical polyethylene glycol (PEG) and its active derivatives. The company's primary products are sold to pharmaceutical companies, research institutions, and medical device manufacturers that use these materials in drug development and production. Technical services such as patent and non-patent technology licensing, as well as R&D services, also contribute to the company's income. The firm's customer segments include entities involved in drug research, development, and production, as well as scientific research organizations. The company's business model focuses on providing specialized materials and technical support for the medical and pharmaceutical sectors. Medical polyethylene glycol and its active derivatives serve as critical components in various medical applications, driving demand from industry partners. By offering both physical products and intellectual property services, Jenkem Technology diversifies its revenue streams within the healthcare technology space. Jenkem Technology Co., Ltd. operates with a clear focus on the medical and pharmaceutical industries, targeting clients that require high-quality PEG-based materials for their research and manufacturing processes. The company's technical services, including licensing and R&D support, further strengthen its position as a supplier of essential materials and solutions in the healthcare sector. Jenkem Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jenkem Technology Co stock

Intangible Assets of Jenkem Technology Co is 40.00 M CNY in 2024.

Intangible Assets of Jenkem Technology Co changed from 20.00 M CNY to 40.00 M CNY, representing a 100.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Jenkem Technology Co since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Jenkem Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Jenkem Technology Co

All Key Metrics — Jenkem Technology Co